NASDAQ:ZVSA

Zyversa Therapeutics Stock Forecast

etoro logo Buy ZVSA
*Your capital is at risk
$0.170
-0.0002 (-0.118%)
At Close: Jun 02, 2026
AI Analysis AI Analysis of ZVSA AI-Powered Market Insights
Stock Analysis PRO New!
Risk Assessment PRO New!
Trading Strategy PRO New!
Add ZVSA to Watchlist?
Some Reasons Why To Add ZVSA:
  • Beat earnings estimates in 3 of the last 4 quarters
  • Healthy interest coverage ratio of 4,060.4x
  • Highly efficient cash conversion (100% FCF/OCF ratio)
PDF

Big movements in ZyVersa Therapeutics, Inc. stock price on Tuesday moving 19.03% between high and low
(Updated on Jun 02, 2026)

SIGN UP FREE
or
Creating an account or logging in means you agree to StockInvest.us Terms of Use and Privacy Policy.
Sell candidate since Jun 01, 2026 Loss -0.12%

The ZyVersa Therapeutics, Inc. stock price fell by -0.118% on the last day (Tuesday, 2nd Jun 2026) from $0.170 to $0.170. It has now fallen 3 days in a row. During the last trading day the stock fluctuated 19.03% from a day low at $0.170 to a day high of $0.202. The price has fallen in 6 of the last 10 days and is down by -13.13% for this period. Volume fell on the last day along with the stock, which is actually a good sign as volume should follow the stock. On the last day, the trading volume fell by -3 thousand shares and in total, 175 shares were bought and sold for approximately $29.75 .

The stock lies in the middle of a very wide and falling trend in the short term and further fall within the trend is signaled. Given the current short-term trend, the stock is expected to fall -22.24% during the next 3 months and, with a 90% probability hold a price between $0.117 and $0.167 at the end of this 3-month period. Do note, that if the stock price manages to stay at current levels or higher, our prediction target will start to change positively over the next few days as the conditions for the current predictions will be broken.

ZVSA Signals & Forecast

Furthermore, there is a buy signal from the 3 month Moving Average Convergence Divergence (MACD). Some negative signals were issued as well, and these may have some influence on the near short-term development. The ZyVersa Therapeutics, Inc. stock holds sell signals from both short and long-term Moving Averages giving a more negative forecast for the stock. Also, there is a general sell signal from the relation between the two signals where the long-term average is above the short-term average. On corrections up, there will be some resistance from the lines at $0.191 and $0.198. A break-up above any of these levels will issue buy signals. A sell signal was issued from a pivot top point on Monday, May 04, 2026, and so far it has fallen -23.08%. Further fall is indicated until a new bottom pivot has been found. Volume fell along with the price during the last trading day which is technical positive. One should, however, note that this stock may have low liquidity in periods, which increases the general risk. The very low volume increases the risk and reduces the other technical signals issued.

Support, Risk & Stop-loss for ZyVersa Therapeutics, Inc. stock

There is no support from accumulated volume below today's level and given the right condition the stock may perform very badly in the next couple of days.

This stock may move much during the day (volatility) and with periodic low trading volume this stock is considered to be "high risk". During the last day, the stock moved $0.0324 between high and low, or 19.03%. For the last week the stock has had daily average volatility of 15.12%.

Our recommended stop-loss: We hold a negative evaluation for this stock. No stop-loss is set.

Trading Expectations (ZVSA) For The Upcoming Trading Day Of Wednesday 3rd

For the upcoming trading day on Wednesday, 3rd we expect ZyVersa Therapeutics, Inc. to open at $0.181, and during the day (based on 14 day Average True Range), to move between $0.157 and $0.183, which gives a possible trading interval of +/-$0.0252 (+/-16.01%) up or down from last closing price. If ZyVersa Therapeutics, Inc. takes out the full calculated possible swing range there will be an estimated 16.01% move between the lowest and the highest trading price during the day.

With no support below and resistance from accumulated volume @ $0.190, some $0.0200 (11.76%) from the current price of $0.170, our system finds the risk reward not very attractive.

Is ZyVersa Therapeutics, Inc. stock A Buy?

ZyVersa Therapeutics, Inc. holds several negative signals and is within a very wide and falling trend, so we believe it will still perform weakly in the next couple of days or weeks. We therefore hold a negative evaluation of this stock. Due to some small weaknesses in the technical picture we have downgraded our analysis conclusion for this stock since the last evaluation from a Sell to a Strong Sell candidate.

Current score: -6.061 Strong Sell Candidate Downgraded

Predicted Fair Opening Price

Predicted fair opening price on June 3, 2026 - $0.181 ( 6.34%).

Want to trade but not sure how? Our step-by-step guide can help.
Skip the guide? Open account with our trusted broker* eToro
*Your capital is at risk

ZVSA Performance

Trading levels for ZVSA

StockInvest.us
Full Access. No Commitment. 7 Days Free!
Long & Short-Term Golden Star Lists
AI Stock Analysis*
Top 10 Candidates on Every List
Premium Lists
Ad-FREE Browsing
Advanced Stock Screener

Fibonacci Support & Resistance Levels

Level Price
R3 0.213 25.37%
R2 0.201 18.10%
R1 0.193 13.61%
Price 0.170
S1 0.168 -0.93%
S2 0.161 -5.42%
S3 0.148 -12.69%

Accumulated Volume Support & Resistance Levels

Level Price
R3 0.210 23.53%
R2 0.200 17.65%
R1 0.190 11.76%
Price 0.170
S1 0 -
S2 0 -
S3 0 -

FAQ

What is the symbol for ZyVersa Therapeutics, Inc. Stock and on which exchange is it traded?
The symbol for ZyVersa Therapeutics, Inc. is ZVSA and it is traded on the NASDAQ (NASDAQ Stock Exchange).

Should I buy or sell ZyVersa Therapeutics, Inc. Stock?
ZyVersa Therapeutics, Inc. holds several negative signals and is within a very wide and falling trend, so we believe it will still perform weakly in the next couple of days or weeks. We therefore hold a negative evaluation of this stock. Due to some small weaknesses in the technical picture we have downgraded our analysis conclusion for this stock since the last evaluation from a Sell to a Strong Sell candidate.

How to buy ZyVersa Therapeutics, Inc. Stock?
ZyVersa Therapeutics, Inc. Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy ZyVersa Therapeutics, Inc. Stock.

What's the current price of ZyVersa Therapeutics, Inc. Stock?
As of the end of day on the Jun 02, 2026, the price of an ZyVersa Therapeutics, Inc. (ZVSA) share was $0.170.

What is the 52-week high and low for ZyVersa Therapeutics, Inc. Stock?
The 52-week high for ZyVersa Therapeutics, Inc. Stock is $1.66 and the 52-week low is $0.110.

What is the market capitalization of ZyVersa Therapeutics, Inc. Stock?
As of the Jun 02, 2026, the market capitalization of ZyVersa Therapeutics, Inc. is 1.376M.

When is the next earnings date for ZyVersa Therapeutics, Inc.?
The upcoming earnings date for ZyVersa Therapeutics, Inc. is Aug 13, 2026.
Click to get the best stock tips daily for free!
GOLDEN STAR
Ticker Change Signal Date
RUN
$12.83
18.86% May 06
GLBE
$31.61
5.35% May 05
SAP
$172.39
10.69% May 05
W
WCLD
$27.34
27.18% Apr 29
ADBE
$243.57
7.61% Apr 29

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE